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use of temporal parameters to distinguish pri-
mary from secondary depression, and data are 
lacking to support dystonia severity as a surro-
gate marker of secondary depression [2]. 
Secondly, the majority of reports on comorbid 
affective illness in dystonia refer to patients 
whose mutation carrier status was not ascer-
tained [5]. Finally, the hypothesis of a shared 
genetic etiology of primary dystonia and major 
depression implies the existence of common 
variants that act as risk modifiers and account 
for differences in heritability of the two condi-
tions. To shed more light on the putative impact 
of TOR1A genetic variants on non-motor pheno-
types, we therefore screened for the ∆GAG 
deletion and other known or novel gene vari-




414 caucasian in- and outpatients from the 
Upper Palatinate region of eastern Bavaria 
(160 men and 254 women, age 48.2 ± 13.2yrs, 
mean ± SD) who presented consecutively to 
Introduction
Early-onset, primary dystonia (DYT1) is a rare 
condition marked by involuntary, sustained 
muscle contractions that typically initiate in the 
lower limbs, and that follow an autosomal domi-
nant mode of inheritance. The disease has 
been linked to TOR1A, the gene encoding torsin 
A on chromosome 9q34, and segregates with a 
3bp deletion, ∆GAG [1]. Observations on psy-
chiatric comorbidity in dystonia patients have 
suggested that DYT1 and major depression 
may share genetic risk factors [2]. This view is 
in line with a mouse model of DYT1 featuring 
alterations in serotonergic transmission [3], a 
hallmark of depressive illness. Finally, hypome-
tabolism in the subgenual cingulate cortex of 
∆GAG deletion carriers would appear to match 
brain metabolic changes observed in depressed 
subjects [4].
However, several open issues remain that war-
rant a follow-up on the proposed dual role of 
the TOR1A gene. Firstly, depressed mood in 
dystonia may be a reaction to impaired motor 
function rather than a preexisting condition. 
The early age of onset in DYT1 precludes the 
Original Article
An examination of TOR1A variants in recurrent major 
depression
Heining FA, Langguth B, Eichhammer P, Domani M, Hajak G, Sand PG
Department of Psychiatry, University of Regensburg, Germany
Received February 20, 2012; accepted February 25, 2012; Epub Feb 28, 2012; Published March 15, 2012
Abstract: Background: Observations of comorbid depression in subjects with primary dystonia have suggested a 
dual role for the TOR1A gene in mood disorders and movement disorders. We conducted a systematic search for 
carriers of the ∆GAG deletion and for other variants in TOR1A exon 5 among 414 Caucasian subjects with recurrent 
major depression from the Upper Palatinate. Findings: Allele frequencies were determined for 27 TOR1A diallelic 
markers, including two novel synonymous substitutions (L262L and E310E) in the region encoding the torsinA C-
terminus, plus four novel variants in the gene’s 3’UTR. No carriers of the ∆GAG deletion were observed. When data 
were compared to previously examined control populations, no significant allelic associations were noted after cor-
rections for multiple testing. Conclusions: The present study adds to the spectrum of TOR1A mutations but provides 
no evidence of a common genetic predisposition to DYT1 dystonia and recurrent major depression. 
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previously described. E310E maps to a highly 
conserved region encoding the C-terminal 
α-helical subdomain α6 which is disrupted by 
the ∆GAG deletion. Genotype distributions of all 
eleven polymorphic variants conformed to the 
HWE (p>0.48). Out of 2048 possible haplo-
types, only three common haplotypes were 
inferred (Figure 1). 
Ten additional variants listed in dbSNP were 
monomorphic in this population: rs10988523, 
rs17849354, rs148036363, rs143571401, 
rs11546836, rs148849547, rs55800846, 
rs1045414, rs1045440, and rs60745320. 
Finally, we observed no carriers of the ∆GAG 
deletion or of other known mutations within the 
region targeted (Table 1). 
For 17 TOR1A variants, reference allele fre-
quencies in healthy Cauacasian populations 
were obtained from the literature and from 
dbSNP (Table 1). When these were compared 
to the respective frequencies in patients diag-
nosed with recurrent major depression, only 
one variant (rs1182) gave an uncorrected p 
value of <0.05, but this finding did not survive 
corrections for multiple testing. Still, a weak 
modulatory effect could not entirely be ruled 
out for rare variants. According to power simu-
lations based on the entire sample of depressed 
patients and all caucasian control populations, 
we should require over 60,000 depressed 
patients and over 1,950,000 healthy controls 
in order to exclude a modifying role of the ∆GAG 
deletion on allelic risk with a statistical power 
of 0.8.
Discussion
The present study extends the mutation spec-
trum at the TOR1A locus but offers little sup-
port for a dual role of this gene in dystonia and 
recurrent major depression. Two female carri-
ers of silent mutations, L262L and E310E aged 
38 and 55 years, respectively, did not present 
with any clinical signs of dystonia. The negative 
association finding for all TOR1A variants inves-
tigated in recurrent major depression is in line 
with eight genome-wide linkage analyses none 
of which have produced any noteworthy signals 
for major depression at 9q34 (reviewed by 
Middeldorp et al. [6]). On the one hand, we 
acknowledge that minor effects of rare variants 
on the risk for recurrent major depression can-
not be entirely dismissed and more TOR1A vari-
our department between 1998 and 2005, pro-
vided written informed consent and were 
included in the study. The study protocol was 
approved by the local Ethics Committee at the 
University of Regensburg. For inclusion in the 
study, a clinical diagnosis of recurrent major 
depression by at least two experienced psychi-
atrists was required according to DSM IV 
criteria. 
Mutation screening
Genomic DNA was extracted from lymphocytes 
using standard procedures prior to amplifica-
tion of the region harboring the ∆GAG deletion 
in the TOR1A terminal exon. Briefly, a 847bp 
amplicon was generated using the following 
oligomers: 5’-TGG ATG AAC AGC ACC TTG TT-3’ 
(forward) and 5’-GGA CCA TCC TGG GAC AGA-3’ 
(reverse). PCR products were purified with 
ExoSAP-IT (GE Healthcare, Freiburg, Germany) 
for Sanger sequencing and for the identification 
of DNA variants by comparison with the human 
genome reference (Genome Reference 
Consortium Build 37, June 2011 release). 
Multiple sequence alignments were conducted 
with DNA Dynamo 1.0 (Blue Tractor Software, 
UK).
Statistical analysis
STATA 8.0 (Stata Corporation, College Station, 
TX, USA) was used for descriptive statistics, 
and for conducting tests of allelic association. 
TOR1A allele frequencies from reference popu-
lations were retrieved from the literature and 
from human variation databases for compari-
son with the present data using Fisher’s exact 
test. The level of statistical significance was set 
at p<0.05 and a Bonferroni correction was 
applied to account for multiple comparisons. 
Linkage disequilibrium and conformity of geno-
type distributions with the Hardy-Weinberg 
equilibrium (HWE) was measured with 
HaploView 4.2.
Results
We identified two variants in the coding region 
and nine variants in the TOR1A 3’-untranslated 
region (3’UTR) with minor allele frequencies 
ranging from 0.001 to 0.229 (Table 1). Of 
these, the coding variants (L262L and E310E), 
and four variants in the gene’s 3’UTR (G1192A, 
G1200A, G1411T, and T1415G) have not been 
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Table 1. Observed genotype and allele frequencies for the TOR1A sequence screened in subjects with recurrent major depression (N=414) and 
tests for allelic association using Caucasian control populations. Eleven confirmed variants are shaded. 
SNP identifier chr9 position major>minor alleles predicted TOR1A 
protein variant






rs10988523 132,576,494 C>T F252F 0.000 0.000 (60)                  a n.s.
0.000 (150)             [9] n.s.
rs17849354 132,576,475 G>C D259H 0.000 0.000 (150)             [9] n.s.
C786A (novel) 132,576,464 C>A L262L 0.001 0.000 (812)          [10] n.s.
rs148036363 132,576,427 A>G K275E 0.000 0.0004 (3510)           b n.s.
- 132,576,387 G>A R288Q 0.000 0.000 (150)             [9] n.s.
rs143571401 132,576,363 A>G I296V 0.000 0.0001 (3510)            b n.s.
- 132,576,359 A>C V297V 0.000 0.0001 (3510)            b n.s.
- 132,576,344-6 GAG>del E302del 0.000 0.000 (150)              [9] n.s.
0.000 (812)           [10] n.s.
0.00004 (12,000) [11] n.s.
0.000 (521)            [12] n.s.
G930A (novel) 132,576,320 G>A E310E 0.001 0.000 (150)              [9] n.s.
- 132,576,313-16 AGAG>del E312STOP325 0.000 0.0006 (812)          [10] n.s.
rs11546836 132,576,293 C>T C319C 0.000 0.000 (150)              [9] n.s.
- 132,576,266-83 G>A F323_Y328del 0.000 0.000 (812)            [10] n.s.
rs148849547 132,576,260 C>T Y330Y 0.000 0.0004 (3510)             b n.s.
- 132,576,244 - 0.000 0.0001 (3510)             b n.s.
rs1182 132,576,060 G>T - 0.229 0.244 (521)            [12] n.s.
0.177 (254)            [13] 0.025 (0.725)
0.221 (242)            [14] n.s.
0.157 (99)               [15] 0.026 (0.754)
0.210 (46)                     c n.s.
0.236 (36)                     d n.s.
G1192A (novel) 132,576,058 G>A - 0.004 - -
G1200A (novel) 132,576,050 G>A - 0.001 - -
rs1183 132,576,037 C>G - 0.078 0.075 (60)                     e n.s.
0.062 (24)                     f n.s.
0.069 (36)                     g n.s.
rs55800846 132,576,034 G>A - 0.000 - -
rs1045414 132,576,024 A>G - 0.000 - -
rs1045440 132,575,860 T>C - 0.000 - -
G1411T (novel) 132,575,839 G>T - 0.003 - -
rs35153737 132,575,837 G>del - 0.227 - -
rs60745320 132,575,835-6 TT>TCT - 0.000 - -
T1415G (novel) 132,575,835 T>G - 0.035 - -
T1422del 132,575,828 T>del - 0.026 - -
rs1045441 132,575,797 T>A - 0.078 0.075 (60)                    h n.s.
0.069 (36)                     i n.s.
all alleles refer to the transcribed strand, MAF = minor allele frequency. adbSNP ss19032613; breference population of European ancestry from the NHLBI GO Exome Sequenci-
ng Project. Data retrieved with the Exome Variant Server (URL: http://evs.gs.washington.edu/EVS/), accessed Feb. 2012; cdbSNP ss43890027; ddbSNP ss123594382; edbSNP 
ss10540562; fdbSNP ss23585341; gdbSNP ss123594377; hdbSNP ss2160149; idbSNP ss123594365.
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non-carriers, the criteria applied to distinguish 
non-manifesting from manifesting subjects 
and, finally, to investigator blinding issues. 
Severe dystonia pervades many aspects of life 
that are routinely addressed in screenings for 
depression, e.g. the level of functioning, family 
and social relationships. Therefore, despite the 
use of telephone interviews, such assessments 
are liable to disclose the handicap.
We note that under the hypothesis of a shared 
etiology in dystonia and major depression, one 
should expect some crossmodal activity of anti-
depressants in dystonia. However, trials of anti-
depressants and structurally related com-
pounds in dystonia have disappointed [7]. 
Instead, dystonia appears to be precipitated or 
worsened by many antidepressants [8]. Non-
pharmacological antidepressant treatment has 
ants exist than were genotyped. On the other 
hand, the previously claimed association may 
stem from overestimating the prevalence of 
recurrent major depression in ∆GAG deletion 
carriers [2], owing to the relatedness of sub-
jects, a disproportionately small number of 
Figure 1. (A) LD plot and R2 x100 values for the eleven TOR1A variants identified 
Figure 1. (B) common haplotypes inferred from these 
variants in the population under study.
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[12] Kamm C, Asmus F, Mueller J, Mayer P, Sharma 
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also failed to produce lasting effects on the 
motor phenotype [5]. 
Taken together, the existing data call for a cau-
tious stand on the alleged contribution of 
TOR1A to the etiology of recurrent major 
depression, in addition to its established 
impact on DYT1. 
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